Our Leadership

Standing Committees

Biosimilars Committee

Gillian Woollett, M.A., D.Phil.
Chair, IGBA Biosimilars Committee

VP, Head Regulatory Strategy and Policy
Samsung Bioepis US (SBUS)

Giuseppe Randazzo
Vice-Chair, IGBA Biosimilars Committee

Vice President of Sciences and Regulatory Affairs
Association for Accessible Medicines (AAM)

Thomas Kirchlechner, M.Sc., PhD
Vice-Chair, IGBA Biosimilars Committee

Director Regulatory Policy
SANDOZ

International External Engagements Committee

James Pfitzer
Chair, IGBA International External Engagements Committee

Senior Director, Global Policy, Corporate Affairs
Viatris

Mark Grossien
Vice-Chair, IGBA International External Engagements Committee

Head of Strategic Communications
Sandoz

Hanan Sboul, M.B.A., B. Pharm, CAE
Vice-Chair, IGBA International External Engagements Committee

Secretary General
Jordanian Association of Pharmaceutical Manufacturers

International Trade and Intellectual Property Committee

Science Committe

Nicholas Cappuccino

Chair, IGBA Science Committe

Chief Executive Officer and Principal Regulatory Consultant
Pharmaceutical Intellectual Resource Services LLC

David Gaugh

Vice-Chair, IGBA Science Committe

Interim CEO
Association for Accessible Medicines (AAM)

Kristin Willemsen

Vice-Chair, IGBA Science Committe

Vice President of Scientific & Regulatory Affairs
CGPA

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

C/O DYN SA
Rue de Cornavin 11
1201 Geneva, Switzerland

E-mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on: Twitter - LinkedIn - YouTube

About IGBA

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.
I accept cookies from this site Agree